Herein, esketamine was found to alleviate LPS-induced inflammation and oxidative stress in ARDS mice, as evidenced by reduced releases of IL-6, IL-1β, TNF-α, and MPO, decreased ROS and MDA concentration, and increased GSH-Px and SOD activities. This evidence concerns the gene SOD1 and acute respiratory distress syndrome.